Lindbrook Capital, LLC Alkermes Plc. Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 413 shares of ALKS stock, worth $14,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
413
Previous 389
6.17%
Holding current value
$14,822
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
372Shares Held
175MCall Options Held
140KPut Options Held
143K-
Black Rock Inc. New York, NY29.1MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$440 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$316 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$271 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.9B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...